As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.
9 Analysts have issued a Fortress Biotech, Inc. forecast:
9 Analysts have issued a Fortress Biotech, Inc. forecast:
Jun '25 |
+/-
%
|
||
Revenue | 59 59 |
28%
28%
|
|
Gross Profit | 42 42 |
26%
26%
|
|
EBITDA | -103 -103 |
14%
14%
|
EBIT (Operating Income) EBIT | -108 -108 |
14%
14%
|
Net Profit | -24 -24 |
51%
51%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Fortress Biotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel pharmaceutical and biotechnology products. It operates through the following segments: Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development. The company was founded on June 28, 2006 and is headquartered in New York, NY.
Head office | United States |
CEO | Lindsay Rosenwald |
Employees | 101 |
Founded | 2006 |
Website | www.fortressbiotech.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.